About: The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review
Creator	Kaidar-Person, Orit Meattini, Icro Poortmans, Philip Ay, Ho Birgitte, Vrou Bv, Offersen Cheng, Skye Hung-Chun Coles, Charlotte Gn, Marta Hijal, Tarek Ho, Alice Marta, Gustavo Offersen, Offersen, Philip Pignol, Jean-Philippe Poortmans, Ramiah, Duvern Sancho, Gemma Sh-Chun, Cheng Zissiadis, Yvonne
Source	Elsevier; PMC
abstract	Post-operative radiation therapy (RT) reduces loco-regional recurrence rates and mortality in most patients with non-metastatic breast cancer. The aim of this critical review is to provide an overview of the applicability of moderately hypofractionated RT for breast cancer patients, focusing on factors influencing clinical decision-making. An international group of radiation oncologists agreed to assess, integrate, and interpret the existing evidence into a practical report to guide clinicians in their daily management of breast cancer patients. We conclude that moderately hypofractionated RT to the breast, chest wall (with/without breast reconstruction), and regional lymph nodes is at least as safe and effective as conventionally fractionated regimens and could be considered as the treatment option for the vast majority of the patients.For those who are still concerned about its generalised application, we recommend participating in ongoing trials comparing moderately hypofractionated RT to conventionally fractionated RT for breast cancer patients in some clinical circumstances.
has issue date	2020-08-26(xsd:dateTime)
bibo:doi	10.1016/j.critrevonc.2020.103090
has license	no-cc
sha1sum (hex)	51a55370b1895821a2097577f8d317c7f9e17cae
schema:url	https://doi.org/10.1016/j.critrevonc.2020.103090
resource representing a document's title	The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review
has PubMed Central identifier	PMC7448956
schema:publication	Crit Rev Oncol Hematol
resource representing a document's body	covid:51a55370b1895821a2097577f8d317c7f9e17cae#body_text
is schema:about of	named entity 'RUA' named entity 'PHONE' named entity 'Zip Code' named entity 'radiation therapy' named entity 'clinical practice' named entity 'hypofractionation' named entity 'follow-up' named entity 'radiobiological' named entity 'post-mastectomy' named entity 'breast-conserving surgery' named entity 'breast tumours' named entity 'oncological' named entity 'non-significant' named entity 'EORTC' named entity 'telangiectasia' named entity 'genetic susceptibility' named entity 'biological effective dose' named entity 'breast pain' named entity 'randomly assigned' named entity 'hypofractionation' named entity '95% CI' named entity 'tissue damage' named entity 'Breast reconstruction' named entity 'radiobiological' named entity 'hypofractionation' named entity 'post-mastectomy' named entity 'equivalent dose' named entity 'breast-conserving surgery' named entity 'lung' named entity 'malignancies' named entity 'correlation' named entity 'equivalent dose' named entity 'follow-up' named entity 'early-stage' named entity 'post-mastectomy' named entity 'radiobiological' named entity '4.3' named entity 'COVID-19 pandemic' named entity 'Post-operative' named entity 'heart disease' named entity 'regional lymph nodes' named entity 'nerve tissue' named entity 'trial design' named entity 'lungs' named entity 'radiation therapy' named entity '2.0' named entity 'equivalent dose' named entity 'tissue injury' named entity 'oedema' named entity 'mastectomy' named entity 'breast cancer' named entity 'Database study' named entity 'telangiectasia' named entity 'brachial plexus' named entity 'anatomy' named entity 'breast cancer' named entity 'therapeutic radiation' named entity 'hypofractionation' named entity 'infection' named entity 'radiobiological' named entity 'treatment group' named entity 'hypofractionation' named entity 'breast-conserving surgery' named entity 'chemotherapy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software